2017
DOI: 10.1016/j.ajo.2017.08.015
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric Corneal Cross-linking: Comparison of Visual and Topographic Outcomes Between Conventional and Accelerated Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
24
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 26 publications
1
24
0
Order By: Relevance
“…17 4 CHU9D: Child Health Utility 9D. 18 J o u r n a l P r e -p r o o f CHU9D utility score 0.9 (0.1) 0.9 (0.1) 0.9 (0.1)…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…17 4 CHU9D: Child Health Utility 9D. 18 J o u r n a l P r e -p r o o f CHU9D utility score 0.9 (0.1) 0.9 (0.1) 0.9 (0.1)…”
Section: Discussionmentioning
confidence: 99%
“…[12][13][14][15][16][17] Treatment of young patients by conventional ('Dresden') and accelerated CXL protocols have been reported to be similarly effective. 18 However more robust randomized evidence is required to inform practice, particularly in children and adolescents for whom there are few published studies.…”
mentioning
confidence: 99%
“…Keratoconus (KC) is a progressive, bilateral, thinning disorder of the cornea in which biomechanical changes in corneal collagen fibers result in progressive increase in corneal curvature and thinning 1,2. Occurring at an estimated (variable) prevalence in the general population of approximately 1:375 to 1:2,000, patients usually present with a deterioration in visual acuity secondary to myopia and irregular astigmatism.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, Mazzotta et al also had a higher percentage of KC progression within a 10-year follow-up after standard CXL in 13 eyes (24% of the study eyes). 26 By contrast, Tian et al, 14 Sarac et al, 15 Baenninger et al, 16 and Badawi 27 report that no complications occurred in their studies of pediatric keratoconus treatments. Tian et al conclude that accelerated transepithelial CXL is a safe and effective procedure to treat progressive KC in pediatric patients.…”
Section: Discussionmentioning
confidence: 97%
“…[11][12][13] Other studies have also reported good results with CXL and ICRS implantation in pediatric KC. [14][15][16] To determine whether CXL-Plus could provide similarly good results in the treatment of pediatric KC, our study aimed to analyze the visual and refractive outcomes with respect to the stability and effectiveness of CXL combined with femtosecond laser ICRS implantation in pediatric KC.…”
Section: Introductionmentioning
confidence: 99%